sumatriptan has been researched along with Aura in 7 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serotonin and fluoxetine, but not sumatriptan, alleviated PTZ-induced seizures by prolonging onset times of myoclonic-jerk and generalized tonic-clonic seizures." | 8.12 | Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats. ( Kilinc, E; Kılınc, YB; Torun, IE, 2022) |
| "Topiramate is a new antiepileptic drug (AED) that has been approved worldwide (in more than 80 countries) for the treatment of various kinds of epilepsy." | 4.82 | Pharmacokinetic interactions of topiramate. ( Bialer, M; Curtin, C; Doose, DR; Murthy, B; Schwabe, S; Twyman, RE; Wang, SS, 2004) |
| "Serotonin and fluoxetine, but not sumatriptan, alleviated PTZ-induced seizures by prolonging onset times of myoclonic-jerk and generalized tonic-clonic seizures." | 4.12 | Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats. ( Kilinc, E; Kılınc, YB; Torun, IE, 2022) |
| " The proportions of outcomes with birth defects are as follows: in the Acyclovir (antiviral medication) Pregnancy Registry (1984-1998) (19/581), 3." | 3.70 | Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. ( Andrews, EB; Ephross, SA; Heffner, CR; Reiff-Eldridge, R; Tennis, PS; White, AD, 2000) |
| "Headache is one of the most common symptoms of COVID." | 2.82 | Post-COVID Headache: A Literature Review. ( Chhabra, N; Grill, MF; Singh, RBH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Torun, IE | 1 |
| Kılınc, YB | 1 |
| Kilinc, E | 1 |
| Chhabra, N | 1 |
| Grill, MF | 1 |
| Singh, RBH | 1 |
| Bialer, M | 1 |
| Doose, DR | 1 |
| Murthy, B | 1 |
| Curtin, C | 1 |
| Wang, SS | 1 |
| Twyman, RE | 1 |
| Schwabe, S | 1 |
| Jacob, J | 1 |
| Goadsby, PJ | 1 |
| Duncan, JS | 1 |
| Ogunyemi, A | 1 |
| Adams, D | 1 |
| Putnam, GP | 1 |
| O'Quinn, S | 1 |
| Bolden-Watson, CP | 1 |
| Davis, RL | 1 |
| Gutterman, DL | 1 |
| Fox, AW | 1 |
| Reiff-Eldridge, R | 1 |
| Heffner, CR | 1 |
| Ephross, SA | 1 |
| Tennis, PS | 1 |
| White, AD | 1 |
| Andrews, EB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Sumatriptan and Naratriptan Pregnancy Registry[NCT01059604] | 868 participants (Actual) | Observational [Patient Registry] | 2001-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for sumatriptan and Aura
| Article | Year |
|---|---|
Post-COVID Headache: A Literature Review.
Topics: COVID-19; Epilepsy; Female; Headache; Humans; Migraine Disorders; Sumatriptan | 2022 |
Pharmacokinetic interactions of topiramate.
Topics: Anticonvulsants; Area Under Curve; Contraceptives, Oral; Drug Interactions; Epilepsy; Fructose; Half | 2004 |
5 other studies available for sumatriptan and Aura
| Article | Year |
|---|---|
Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats.
Topics: Animals; Anticonvulsants; Epilepsy; Fluoxetine; Humans; Interleukin-6; Male; Neuroinflammatory Disea | 2022 |
Use of sumatriptan in post-ictal migraine headache.
Topics: Adult; Epilepsy; Female; Humans; Male; Middle Aged; Migraine Disorders; Sumatriptan | 1996 |
Migraine-like symptoms triggered by occipital lobe seizures: response to sumatriptan.
Topics: Adult; Electroencephalography; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Male; Migraine | 1998 |
Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-As | 1999 |
Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
Topics: Abnormalities, Drug-Induced; Acyclovir; Anticonvulsants; Antiviral Agents; Drug Industry; Epilepsy; | 2000 |